[{"NetIncomeLoss_1_Q1_USD":-65664000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":26296000.0,"InterestPaidNet_1_Q1_USD":7513000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":86565000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q1_USD":132000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":30242000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":14194000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":608000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":10000.0,"AssetsCurrent_0_Q1_USD":502891000.0,"LongTermDebt_0_Q1_USD":389789000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":46726000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":5069000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":6539000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4161000.0,"InventoryValuationReserves_0_Q1_USD":200000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":7521000.0,"IncomeTaxesPaidNet_1_Q1_USD":2472000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q1_USD":21000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":163680000.0,"CommonStockSharesIssued_0_Q1_shares":266007718.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":10023000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":232596000.0,"Assets_0_Q1_USD":810034000.0,"ShareBasedCompensation_1_Q1_USD":20354000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":23008000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":22363000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":9020000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":264369317.0,"FinanceLeasePrincipalPayments_1_Q1_USD":368000.0,"AssetsFairValueDisclosure_0_Q1_USD":236491000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-3200000.0,"AccountsReceivableNetCurrent_0_Q1_USD":44931000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1582000.0,"CommonStockValue_0_Q1_USD":2680000.0,"WarrantsAndRightsOutstanding_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-40191000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1604000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":-471000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":64117000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":8829000.0,"DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_0_Q1_USD":3946000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-741000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":57178000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-65056000.0,"OtherAssetsNoncurrent_0_Q1_USD":20538000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":184833000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":44431000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2350507000.0,"Liabilities_0_Q1_USD":559138000.0,"DeferredCreditsAndOtherLiabilitiesNoncurrent_0_Q1_USD":7406000.0,"MarketableSecuritiesCurrent_0_Q1_USD":232596000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":471000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-7669000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"Goodwill_0_Q1_USD":197797000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-64082000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":20354000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-72354000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":3709000.0,"ProceedsFromWarrantExercises_1_Q1_USD":19230000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":19600000.0,"LiabilitiesCurrent_0_Q1_USD":99652000.0,"AccountsPayableCurrent_0_Q1_USD":16110000.0,"InterestExpense_1_Q1_USD":7992000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":23000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":188049000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4161000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":184833000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":23000000.0,"GrossProfit_1_Q1_USD":59863000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":-185000.0,"DebtSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":114500000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":4896000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":188000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":6696000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":43445000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":21730000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":608000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":15961000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":76247000.0,"OperatingIncomeLoss_1_Q1_USD":-53055000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":100000.0,"InventoryNet_0_Q1_USD":18801000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":26296000.0,"InvestmentIncomeInterest_1_Q1_USD":165000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":810034000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":20354000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":332000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":6764000.0,"OperatingExpenses_1_Q1_USD":112918000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.25,"ProfitLoss_1_Q1_USD":-65664000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":6268000.0,"StockholdersEquity_0_Q1_USD":250896000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":868000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":232583000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":3216000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":66402000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":555000.0,"DebtConversionConvertedInstrumentSharesIssued1_1_Q1_shares":4100.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2111126000.0,"PaymentsForTenantImprovements_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":21887000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-839000.0,"CommonStockSharesOutstanding_0_Q1_shares":266007718.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1153000.0,"Ticker":"FOLD","CIK":"1178879","name":"AMICUS THERAPEUTICS, INC.","OfficialName":"Amicus Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2296240629.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]